IFLYTEK(SZ:002230) Cai Jing Wang·2025-08-21 16:18Core Insights - The company reported a record revenue of 10.911 billion yuan for the first half of 2025, marking a year-on-year growth of 17.01% [1] - Gross profit reached 4.389 billion yuan, an increase of 17.12% compared to the same period last year [1] - The AI medical business experienced a revenue growth of 21% year-on-year [1] Business Expansion - As of June 30, the company's AI medical assistant has expanded to 697 counties and over 75,000 grassroots medical institutions, providing over 1.01 billion AI-assisted diagnosis suggestions [1] - The company has identified 110 million unreasonable prescriptions through its AI systems [1] - The personal medical AI assistant app, iFlytek Xiaoyi, has completed over 140 million AI consultations, with a user satisfaction rate of 98% and a recommendation rate of 46% [1] Strategic Development - The chronic disease management system is accelerating nationwide deployment, covering over 120 key counties in more than 10 provinces [1] - The company is building barriers by enhancing diagnostic capabilities at grassroots levels and preventing misdiagnosis through collaborations with top hospitals [1] Industry Recognition - In June 2025, the MedBench evaluation ranked the iFlytek Spark Medical Model first with a comprehensive score of 95.4, excelling in complex medical reasoning, medical language understanding, and medical safety and ethics [1]